Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis

Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis

Bibliographic Details
Main Authors:	Awadhesh Kumar Singh, Ritu Singh
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=1;spage=4;epage=10;aulast=Singh

Similar Items

Cardiovascular outcomes of antidiabetic drugs
by: Ranjit Kumar Nath, et al.
Published: (2021-03-01)

SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins
by: Awadhesh K Singh, et al.
Published: (2019-01-01)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
by: Chris Wai Hang Lo, et al.
Published: (2021-03-01)

Triglyceride and cardiovascular risk: A critical appraisal
by: Awadhesh Kumar Singh, et al.
Published: (2016-01-01)

Heart failure hospitalization with DPP-4 inhibitors: A systematic review and meta-analysis of randomized controlled trials
by: Awadhesh Kumar Singh, et al.
Published: (2019-01-01)

Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review
by: Awadhesh Kumar Singh, et al.
Published: (2016-01-01)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
by: Mario Schubert, et al.
Published: (2020-09-01)

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
by: Georg Wolff, et al.
Published: (2023-02-01)

Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis.
by: Gyeongsil Lee, et al.
Published: (2017-01-01)

Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
by: Awadhesh Kumar Singh, et al.
Published: (2020-01-01)

Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
by: Awadhesh Kumar Singh, et al.
Published: (2015-01-01)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
by: BMY Cheung, et al.
Published: (2020-05-01)

Metformin in gestational diabetes: An emerging contender
by: Awadhesh Kumar Singh, et al.
Published: (2015-01-01)

Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom
by: Vanessa C. Brunetti, et al.
Published: (2022-09-01)

Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
by: Stefan D. Anker
Published: (2019-12-01)

Adaptive workflow scheduling in grid computing based on dynamic resource availability
by: Ritu Garg, et al.
Published: (2015-06-01)

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
by: Vallo Volke, et al.
Published: (2022-10-01)

Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach
by: Awadhesh Kumar Singh
Published: (2014-01-01)

Recent trials in cardiology: Newer evidence in prevention of cardiovascular disease
by: Gagandeep Singh Wander
Published: (2016-01-01)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
by: Awadhesh K Singh, et al.
Published: (2021-01-01)

Nephroprotective Properties of Antidiabetic Drugs
by: Christian Gerdes, et al.
Published: (2023-05-01)

Antidiabetic drugs and kidney disease
by: Anne Zanchi, et al.
Published: (2012-09-01)

The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective
by: Tomislav Kurevija, et al.
Published: (2024-03-01)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
by: Amelia D. Dahlén, et al.
Published: (2022-01-01)

Effect of Oral Antidiabetic Drugs on Tuberculosis Risk and Treatment Outcomes: Systematic Review and Meta-Analysis
by: Edinson Dante Meregildo-Rodriguez, et al.
Published: (2022-10-01)

Marketing analysis of the pharmaceutical market of antidiabetic drugs in Ukraine
by: A. O. Savych, et al.
Published: (2022-04-01)

Cardiovascular outcomes among participants with diabetes in the recent large statin trials.
by: Armitage, J, et al.
Published: (2004)

Bullosis Diabeticorum involving an unusual site- a diagnostic dilemma; managed successfully with antidiabetic drugs: A case report
by: Rakesh Tilak Raj, et al.
Published: (2014-07-01)

Comparative study of three brands of antidiabetic drug, empagliflozin available in Karachi, Pakistan
by: Khadija Aslam, et al.
Published: (2023-04-01)

Effects of antidiabetic drugs on bone metabolism
by: Padilla Apuntate Nuria, et al.
Published: (2024-04-01)

Pharmacogenetics of new classes of antidiabetic drugs
by: Selma Imamovic Kadric, et al.
Published: (2021-12-01)

Antidiabetic Drugs in Breast Cancer Patients
by: Wojciech Garczorz, et al.
Published: (2024-01-01)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
by: Michalis Michailidis, et al.
Published: (2022-04-01)

How many oral antidiabetic drugs before insulin?
by: Jayant Kelwade, et al.
Published: (2017-01-01)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
by: Jörg König, et al.
Published: (2011-10-01)

Mechanisms of cardiovascular protection of non-insulin antidiabetic medications
by: Angelo Avogaro
Published: (2018-11-01)

Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Artur Małyszczak, et al.
Published: (2024-03-01)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
by: Huri HZ, et al.
Published: (2015-08-01)

Associations of antidiabetic drugs with diabetic retinopathy in people with type 2 diabetes: an umbrella review and meta-analysis
by: Luyuan Tan, et al.
Published: (2024-01-01)

New trends in the development of oral antidiabetic drugs.
by: Kecskemeti, V, et al.
Published: (2002)